ISPE Convenes Premier Pharmaceutical Manufacturing Event of the Year in Atlanta, Georgia

Share Article

The 2016 ISPE Annual Meeting & Expo will feature more than 80 education sessions and 200 exhibitors across four days.

ISPE’s goal is to help take the evolving industry to the next level and, ultimately, to contribute to improving patient lives worldwide.

Bethesda, Maryland USA (PRWEB)September 12, 2016

The International Society for Pharmaceutical Engineering (ISPE) will hold its biggest event of the year and one of the premier annual events for pharmaceutical manufacturing next week in Atlanta, Georgia. The 2016 Annual Meeting & Expo being held from 18-21 September, features more than 80 education sessions and 200 exhibitors, designed to help attendees address the issues of providing more effective, quality medicines to patients, through the integration of drug products, biologics, and cutting-edge drug delivery systems.

“ISPE strives to provide world-class education to an international pharmaceutical manufacturing, operations and quality audience at the 2016 Annual Meeting & Expo. ISPE’s goal is to help take the evolving industry to the next level and, ultimately, to contribute to improving patient lives worldwide,” said John Bournas, ISPE President and CEO.

On day two of the conference, attendees will hear from Nicole Pierson the mother of Gavin, a pediatric brain tumor survivor. Diagnosed at age five with a teratoma, a rare form of cancer, he was the first pediatric patient to receive compassionate use for the drug Palbociclib, before it had received FDA approval. Nicole and Gavin will share their personal story of how compassionate use of this drug contributed to saving Gavin’s life. Nicole is an advocate for pediatric brain tumor research and is also the author of "Be Strong and Brave", a memoir about how Gavin's faith and hope saved his life.

About ISPE
The International Society for Pharmaceutical Engineering (ISPE) is the world’s largest not-for-profit association serving its members through leading scientific, technical, and regulatory advancement across the entire pharmaceutical lifecycle. The more than 18,000 members of ISPE are building solutions in the development and manufacture of safe, effective pharmaceutical and biologic medicines, and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters in Bethesda, Maryland, USA, and an operations and training center in Tampa, Florida, USA. Visit http://www.ISPE.org for more information.